The infrequent detection of IgM N antibodies with our assay was surprising but consistent with a prior study that identified no significant differences in N-specific IgM antibodies between healthy donors and recovered COVID-19 patients (23) and with another study that showed similar low levels of N-specific IgM antibody detection between COVID-19 patients and controls (20). The gene discussed is CD40LG; the disease is COVID-19.